Top Buy
| Wertpapier | Buy | Sell | Buy (1M) | Sell (1M) ▲ | Kurs | Kursziel | Potential |
|---|---|---|---|---|---|---|---|
| Biogen Inc. | 53 | 1 | 4 | 0 | 216,60 € | 292,88 € | 35,22 % |
| Amgen Inc. | 28 | 0 | 4 | 0 | 291,80 € | 300,61 € | 3,02 % |
| Repligen Corp. | 14 | 0 | 1 | 0 | 118,30 € | 182,96 € | 54,66 % |
| Immunogen Inc. | 4 | 0 | 0 | 0 | 28,97 € | - | - |
| Natural Alternat. | 18 | 1 | 1 | 0 | 5,60 € | - | - |
| Regeneron Pharmaceuticals Inc. | 47 | 1 | 11 | 0 | 982,60 € | 1.046,4 € | 6,49 % |
| Ionis Pharmaceuticals Inc. | 20 | 5 | 1 | 0 | 44,51 € | 56,72 € | 27,44 % |
| Vertex Pharmaceuticals Inc. | 52 | 2 | 6 | 0 | 437,65 € | 432,21 € | -1,24 % |
| Gilead Sciences Inc | 15 | 1 | 4 | 0 | 64,05 € | 79,54 € | 24,19 % |
| Anika Therapeutics | 5 | 0 | 0 | 0 | 24,00 € | 28,29 € | 17,88 % |
| Biocryst Pharmaceuticals | 9 | 0 | 0 | 0 | 5,78 € | 11,05 € | 91,00 % |
| Incyte Corp. | 12 | 2 | 0 | 0 | 56,60 € | 78,42 € | 38,56 % |
| Merck & Co. Inc. | 33 | 1 | 5 | 0 | 116,80 € | 125,34 € | 7,31 % |
| Neurocrine Bioscience | 33 | 0 | 2 | 0 | 128,55 € | 140,87 € | 9,58 % |
| Geron Corp. | 16 | 0 | 4 | 0 | 3,96 € | 5,10 € | 29,03 % |
| Sarepta Therapeutics | 8 | 0 | 7 | 0 | 147,55 € | 190,00 € | 28,77 % |
| United Therapeutics | 22 | 0 | 3 | 0 | 297,30 € | 289,92 € | -2,48 % |
| BioMarin Pharmaceutical Inc. | 21 | 0 | 1 | 0 | 79,28 € | 102,63 € | 29,45 % |
| Dynavax Technologies Corp | 3 | 0 | 1 | 0 | 10,33 € | 27,02 € | 161,66 % |
| Lexicon Pharmaceuticals Inc. | 4 | 0 | 2 | 0 | 1,57 € | 7,66 € | 386,37 % |
| Exelixis Inc. | 18 | 0 | 0 | 0 | 20,95 € | 26,01 € | 24,14 % |
| Innoviva Inc. | 4 | 0 | 1 | 0 | 15,20 € | 30,00 € | 97,37 % |
| Cytokinetics Inc. | 34 | 1 | 3 | 0 | 48,40 € | 83,21 € | 71,91 % |
| Arrowhead Pharmaceuticals Inc. | 20 | 2 | 6 | 0 | 24,24 € | 54,74 € | 125,84 % |
| Halozyme Therapeutics Inc. | 20 | 0 | 5 | 0 | 48,90 € | 52,75 € | 7,87 % |